Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: M. Gentzsch directs the CFTR Functional Analysis Core of the CF Foundation Research Development Program BOUCHE19R0 and the CF Molecular/Functional Measurement Core of the NIH CFRTCC Program P30DK065988. M. Gentzsch and C.M.P. Ribeiro are recipients of a Boost Award from the School of Medicine at the University of North Carolina and have obtained support for registration (NACFC) or travel (ECFS Conference) to conferences.
Conflict of interest: C.W. Kam reports grants from the CFF, Friends Fighting Cystic Fibrosis, and the American Society of Health-System Pharmacists Foundation.
Conflict of interest: C.J. McKinzie received funding from the CFF and consulting fees from Vertex Pharmaceuticals, Inc.
Conflict of interest: K.A. Despotes received funding from the CFF. C.R. Esther directs a National Resource Center Core that is funded by the CFF and obtained consulting fees from the CFF.
Conflict of interest: B. Baker, D.M. Cholon, S.E. Boyles, and N.L. Quinney report no conflict of interest.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received October 5, 2023.
- Accepted October 18, 2023.
- Copyright ©The authors 2023
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
